Anna Schwendeman - Concepedia

Author

Anna Schwendeman

Also Known As

A Schwendeman, A. Schwendeman, Alan T. Remaley, Anna A Schwendeman, Anna A. Schwendeman, Anna S Schwendeman, Anna Schwendeman, Anna Schwendman, Rui Kuai, Schwendeman,Anna

304

Publications

7.9K

Citations

H-Index

113

Concepts

All Affiliations

University of Michigan BioSurfaces (United States)Center for Drug Evaluation and Research University of Kansas United States Food and Drug Administration

About

Anna Schwendeman is an author at University of Michigan specializing in medicine, engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.8K
2	Engineering	16	18	1.7K
3	Natural Sciences	4	4	98
4	Public Health	1	1	16
5	Anesthesia	1	1	29

Anna Schwendeman

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Designer vaccine nanodiscs for personalized cancer immunotherapy Rui Kuai, Lukasz J. Ochyl, Keith S. Bahjat, Nature Materials NanoparticlesNanomedicineCross-protectionVaccinationEngineering	2016	1K
Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer Jutaek Nam, Sejin Son, Lukasz J. Ochyl, Nature Communications	2018	791
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy Rui Kuai, Wenmin Yuan, Sejin Son, Science Advances	2018	341
High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme Padma Kadiyala, Dan Li, Fernando M. Núñez, ACS Nano	2019	210
Predicting drug release kinetics from nanocarriers inside dialysis bags Minzhi Yu, Wenmin Yuan, Dan Li, Journal of Controlled Release NanomedicinePharmaceutical TechnologyDrug Release KineticsDrug Delivery SystemBiophysics	2019	189
Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy Rui Kuai, Xiaoqi Sun, Wenmin Yuan, Journal of Controlled Release	2018	132
Systemic Delivery of an Adjuvant CXCR4–CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy Mahmoud S. Alghamri, Kaushik Banerjee, Anzar Mujeeb, ACS Nano	2022	132
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice Padma Kadiyala, Stephen V. Carney, Jessica C. Gauss, Journal of Clinical Investigation	2020	131
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Cancer Discovery	2023	130
Injectable MMP-Responsive Nanotube-Modified Gelatin Hydrogel for Dental Infection Ablation Juliana Silva Ribeiro, Ester Alves Ferreira Bordini, Jéssica A. Ferreira, ACS Applied Materials & Interfaces	2020	123

Page 1